首頁 > 市場調查報告書 > 製藥

全球大麻素市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

市場調查報告書

商品編碼

1342892

全球大麻素市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

Global Cannabinoids Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 242 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球大麻素市場需求預計將從 2022 年的 255.4 億美元增至 2030 年近 1964 億美元，2023-2030 年研究期間年複合成長率為 25.44%。

大麻素，也稱為醫用大麻，可以治療疾病或改善其症狀。它們用於控制疼痛、血壓、記憶力、注意力、食慾、感官刺激、肌肉問題和癲癇發作以及其他疾病或健康狀況。該材料還用於身體護理領域，作為身體油、乳液和膠囊的成分。

市場動態：

近年來，使用大麻治療各種醫療疾病在全國越來越受歡迎。市場擴張的推動因素包括客戶對含有大麻素的產品的偏好不斷提高以及公眾對大麻及相關產品的認知不斷提高。政府對大麻素的有利政策也吸引了更多公司進入該行業。此外，有前景的研究表明次要和主要大麻素在治療各種健康問題方面的益處，提高了公眾對大麻使用的認知。然而，預計生產和提取的高成本，特別是小大麻素的成本，將阻礙市場擴張。

該報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球大麻素市場的每個細分市場進行了包容性評估。大麻素行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲大麻素市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。大麻素市場的主要參與者包括 Mylan NV (Viatris Inc.)、Alkem Labs、GW Pharmaceuticals plc、Tilray Inc.、Aurora Cannabis Inc.、Canopy Growth Corporation 和 The Cronos Group。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史和預測數據銷售分析
- 北美按細分市場銷售分析
- 北美按國家/地區銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家/地區銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史和預測數據銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳大利亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家/地區銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史和預測數據銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：大麻素公司的競爭格局

大麻素市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

公司股份分析
市場集中度
Mylan NV (Viatris Inc.)

公司簡介
公司收入
產品
最近的發展

Alkem Labs

公司簡介
公司收入
產品
最近的發展

GW Pharmaceuticals plc

公司簡介
公司收入
產品
最近的發展

Tilray Inc.

公司簡介
公司收入
產品
最近的發展

Aurora Cannabis Inc.

公司簡介
公司收入
產品
最近的發展

Canopy Growth Corporation

公司簡介
公司收入
產品
最近的發展

The Cronos Group

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR11219442

The global demand for Cannabinoids Market is presumed to reach the market size of nearly USD 196.4 BN by 2030 from USD 25.54 BN in 2022 with a CAGR of 25.44% under the study period of 2023 - 2030.

Cannabinoids, also known as medical marijuana, treat diseases or improve their symptoms. They are employed in the control of pain, blood pressure, memory, focus, appetite, sensory stimulation, muscular issues, and seizures, among other disorders or health situations. The material is additionally employed in the body care sector as a component of body oils, lotions, and capsules.

MARKET DYNAMICS:

In recent years, the use of cannabis for various medical ailments has gained popularity in the nation. Market expansion is fueled by elements including rising customer preference for products containing cannabinoids and increasing public awareness of cannabis and related products. Favourable government policies around cannabinoids have also attracted more companies to the industry. Additionally, promising research suggesting the benefits of minor and major cannabinoids in treating various health issues has raised public awareness of cannabis use. However, it is anticipated that the high costs of production and extraction, particularly for small cannabinoids, will impede market expansion.

The report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cannabinoids. The growth and trends of Cannabinoids Industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the cannabinoids market report provides detailed data on the segments by analyzing them at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Cannabidiol
Tetrahydrocannabinol
Cannabinol
Others

By Application

Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others)
Non-Medical Use

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Online Stores

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Cannabinoids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the cannabinoids market include Mylan N.V. (Viatris Inc.), Alkem Labs, GW Pharmaceuticals plc, Tilray Inc., Aurora Cannabis Inc., Canopy Growth Corporation, The Cronos Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CANNABINOIDS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Distribution Channel
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY PRODUCT TYPE

6.1 Overview by Product Type
6.2 Historical and Forecast Data
6.3 Analysis by Product Type
6.4 Cannabidiol Historic and Forecast Sales by Regions
6.5 Tetrahydrocannabinol Historic and Forecast Sales by Regions
6.6 Cannabinol Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Historic and Forecast Sales by Regions
7.5 Non-medical Use Historic and Forecast Sales by Regions

8 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1 Overview by Distribution Channel
8.2 Historical and Forecast Data
8.3 Analysis by Distribution Channel
8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
8.5 Retail Pharmacies Historic and Forecast Sales by Regions
8.6 Online Stores Historic and Forecast Sales by Regions

9 . GLOBAL CANNABINOIDS MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CANNABINOIDS COMPANIES

10.1. Cannabinoids Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CANNABINOIDS INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Mylan N.V. (Viatris Inc.)
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Alkem Labs
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. GW Pharmaceuticals plc
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. Tilray Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Aurora Cannabis Inc.
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. Canopy Growth Corporation
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. The Cronos Group
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Product Type (Tons and USD MN)
Cannabidiol Market Sales by Geography (Tons and USD MN)
Tetrahydrocannabinol Market Sales by Geography (Tons and USD MN)
Cannabinol Market Sales by Geography (Tons and USD MN)
Others Market Sales by Geography (Tons and USD MN)
Analysis Market by Application (Tons and USD MN)
Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Market Sales by Geography (Tons and USD MN)
Non-medical Use Market Sales by Geography (Tons and USD MN)
Analysis by Distribution Channel (Tons and USD MN)
Hospital Pharmacies Market Sales by Geography (Tons and USD MN)
Retail Pharmacies Market Sales by Geography (Tons and USD MN)
Online Stores Market Sales by Geography (Tons and USD MN)
Global Cannabinoids Market Sales by Geography (Tons and USD MN)
North America Market Analysis (Tons and USD MN)
United State Market Analysis (Tons and USD MN)
Canada Market Analysis (Tons and USD MN)
Mexico Market Analysis (Tons and USD MN)
Europe Market Analysis (Tons and USD MN)
Europe Market Estimate by Country (Tons and USD MN)
United Kingdom Market Analysis (Tons and USD MN)
France Market Analysis (Tons and USD MN)
Germany Market Analysis (Tons and USD MN)
Italy Market Analysis (Tons and USD MN)
Russia Market Analysis (Tons and USD MN)
Spain Market Analysis (Tons and USD MN)
Rest of Europe Market Analysis (Tons and USD MN)
Asia Pacific Market Analysis (Tons and USD MN)
China Market Analysis (Tons and USD MN)
Japan Market Analysis (Tons and USD MN)
India Market Analysis (Tons and USD MN)
South Korea Market Analysis (Tons and USD MN)
Australia Market Analysis (Tons and USD MN)
Rest of Asia Pacific Market Analysis (Tons and USD MN)
Latin America Market Analysis (Tons and USD MN)
Brazil Market Analysis (Tons and USD MN)
Argentina Market Analysis (Tons and USD MN)
Peru Market Analysis (Tons and USD MN)
Chile Market Analysis (Tons and USD MN)
Rest of Latin America Market Analysis (Tons and USD MN)
Middle East & Africa Market Analysis (Tons and USD MN)
Saudi Arabia Market Analysis (Tons and USD MN)
UAE Market Analysis (Tons and USD MN)
Israel Market Analysis (Tons and USD MN)
South Africa Market Analysis (Tons and USD MN)
Rest of Middle East and Africa Market Analysis (Tons and USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Cannabinoids Report
Market Research Process
Market Research Methodology
Global Cannabinoids Market Size, by Region (Tons and USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product Type
Market Attractiveness Analysis by Application
Market Attractiveness Analysis by Distribution Channel
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Product Type (Tons and USD MN)
Cannabidiol Market Sales by Geography (Tons and USD MN)
Tetrahydrocannabinol Market Sales by Geography (Tons and USD MN)
Cannabinol Market Sales by Geography (Tons and USD MN)
Others Market Sales by Geography (Tons and USD MN)
Global Market Analysis by Application (Tons and USD MN)
Medicinal Use (Chronic Pain, Neurological Disorders Management, Oncology, Others) Market Sales by Geography (Tons and USD MN)
Non-medical Use Market Sales by Geography (Tons and USD MN)
Global Market Analysis by Distribution Channel (Tons and USD MN)
Hospital Pharmacies Market Sales by Geography (Tons and USD MN)
Retail Pharmacies Market Sales by Geography (Tons and USD MN)
Online Stores Market Sales by Geography (Tons and USD MN)
Global Market Sales (Tons and USD MN)
North America Market Sales (Tons and USD MN)
Europe Market Sales (Tons and USD MN)
Asia Pacific Market Sales (Tons and USD MN)
Latin America Market Sales (Tons and USD MN)
Middle East & Africa Market Sales (Tons and USD MN)
Recent Development in Industry
Top Company Market Share Analysis